Bank of America just raised its EUR/USD forecast
Basel Medical (TASE:BLWV) Group Ltd (NASDAQ:BMGL) announced the appointment of Mr. Tan Boon Chye (Darren) as its chief commercial officer, effective August 15. The decision was made by the company’s board of directors, according to a statement released Thursday based on a filing with the U.S. Securities and Exchange Commission.
Mr. Tan brings experience in business consulting, marketing, financing, and corporate development. He began his entrepreneurial career in 2007 and has co-founded multiple companies across various industries. He holds a Bachelor of Science in Accounting and Finance from the University of London. His professional achievements include receiving the 2010 Successful Entrepreneur Award (Platinum Category) and the 2011 SME1 Asia Emerging Award. He has also been featured by Global Business Magazine, Channel News Asia, and Phoenix Satellite TV.
The company disclosed that Mr. Tan is an equity interest holder in Basel Medical Fund, a subfund of Rainforest Capital VCC, which is the majority and controlling shareholder of Basel Medical Group . The filing stated that there are no family relationships between Mr. Tan and any other director or executive officer of the company.
Basel Medical Group Ltd is based in Singapore and operates in the medical services sector. The information is based on a press release statement filed with the SEC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.